Long-term outcomes of percutaneous tricuspid annuloplasty with Cardioband device.
Ana Pardo SanzJosé Luis Zamorano GómezLuisa Salido TahocesJuan Manuel Monteagudo RuizAna García MartínAriana González GómezRocío Hinojar BaydesMaría Abellás SequeirosMarcelo Sanmartín FernándezJosé Luis Mestre BarcelóEduardo González FerrerSara Fernández SantosCovadonga Fernández-Golfín LobánÁngel Sánchez RecaldePublished in: European heart journal. Cardiovascular Imaging (2022)
Percutaneous annuloplasty with Cardioband system is an effective and safe treatment for patients with symptomatic, ≥severe functional TR. Annular reduction and TR severity reduction remained significant and sustained for 1 year. Patients experienced improvements in quality of life and exercise capacity.
Keyphrases
- mitral valve
- end stage renal disease
- ejection fraction
- minimally invasive
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- physical activity
- radiofrequency ablation
- high intensity
- left ventricular
- aortic stenosis
- early onset
- patient reported outcomes
- drug induced
- replacement therapy
- smoking cessation